Primary brain tumours in adults von Lapointe, Sarah, Perry, Arie, Butowski, Nicholas A

Volltext

MRI Features and IDH Mutational Status of Grade II Diffuse Gliomas: Impact on Diagnosis and Prognosis von Villanueva-Meyer, Javier E, Wood, Matthew D, Choi, Byung Se, Mabray, Marc C, Butowski, Nicholas A, Tihan, Tarik, Cha, Soonmee

Volltext

Randomized trial of neoadjuvant vaccination with tumor-cell lysate induces T cell response in low-grade gliomas von Ogino, Hirokazu, Taylor, Jennie W, Nejo, Takahide, Gibson, David, Watchmaker, Payal B, Okada, Kaori, Saijo, Atsuro, Tedesco, Meghan R, Shai, Anny, Wong, Cynthia M, Rabbitt, Jane E, Olin, Michael R, Moertel, Christopher L, Nishioka, Yasuhiko, Salazar, Andres M, Molinaro, Annette M, Phillips, Joanna J, Butowski, Nicholas A, Clarke, Jennifer L, Oberheim Bush, Nancy Ann, Hervey-Jumper, Shawn L, Theodosopoulos, Philip, Chang, Susan M, Berger, Mitchel S, Okada, Hideho

Volltext

Heat-shock protein peptide complex-96 vaccination for recurrent glioblastoma: a phase II, single-arm trial von Bloch, Orin, Crane, Courtney A, Fuks, Yelena, Kaur, Rajwant, Aghi, Manish K, Berger, Mitchel S, Butowski, Nicholas A, Chang, Susan M, Clarke, Jennifer L, McDermott, Michael W, Prados, Michael D, Sloan, Andrew E, Bruce, Jeffrey N, Parsa, Andrew T

Volltext

Treatment options for recurrent high-grade gliomas von Birk, Harjus S, Han, Seunggu J, Butowski, Nicholas A

Volltext

CDK 4/6 inhibitors for the treatment of meningioma von Young, Jacob S., Kidwell, Reilly L., Zheng, Allison, Haddad, Alex F., Aghi, Manish K., Raleigh, David R., Schulte, Jessica D., Butowski, Nicholas A.

Volltext

Diagnosis and Treatment of Recurrent High-Grade Astrocytoma von Butowski, Nicholas A, Sneed, Patricia K, Chang, Susan M

Volltext

Clinical outcome and prognostic factors for central neurocytoma: twenty year institutional experience von Imber, Brandon S., Braunstein, Steve E., Wu, Fred Y., Nabavizadeh, Nima, Boehling, Nicholas, Weinberg, Vivian K., Tihan, Tarik, Barnes, Michael, Mueller, Sabine, Butowski, Nicholas A., Clarke, Jennifer L., Chang, Susan M., McDermott, Michael M., Prados, Michael D., Berger, Mitchel S., Haas-Kogan, Daphne A.

Volltext

Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma von Cloughesy, Timothy F., Mochizuki, Aaron Y., Orpilla, Joey R., Hugo, Willy, Lee, Alexander H., Davidson, Tom B., Wang, Anthony C., Ellingson, Benjamin M., Rytlewski, Julie A., Sanders, Catherine M., Kawaguchi, Eric S., Du, Lin, Li, Gang, Yong, William H., Gaffey, Sarah C., Cohen, Adam L., Mellinghoff, Ingo K., Lee, Eudocia Q., Reardon, David A., O’Brien, Barbara J., Butowski, Nicholas A., Nghiemphu, Phioanh L., Clarke, Jennifer L., Arrillaga-Romany, Isabel C., Colman, Howard, Kaley, Thomas J., de Groot, John F., Liau, Linda M., Wen, Patrick Y., Prins, Robert M.

Volltext

The Development of Reduced Diffusion Following Bevacizumab Therapy Identifies Regions of Recurrent Disease in Patients with High-grade Glioma von Barajas, Ramon F., MD, Butowski, Nicholas A., MD, Phillips, Joanna J., MD, PhD, Aghi, Manish K., MD, PhD, Berger, Mitchel S., MD, Chang, Susan M., MD, Cha, Soonmee, MD

Volltext

Infigratinib in Patients with Recurrent Gliomas and FGFR Alterations: A Multicenter Phase II Study von Lassman, Andrew B, Sepúlveda-Sánchez, Juan Manuel, Cloughesy, Timothy F, Gil-Gil, Miguel J, Puduvalli, Vinay K, Raizer, Jeffrey J, De Vos, Filip Y F, Wen, Patrick Y, Butowski, Nicholas A, Clement, Paul M J, Groves, Morris D, Belda-Iniesta, Cristóbal, Giglio, Pierre, Soifer, Harris S, Rowsey, Steven, Xu, Cindy, Avogadri, Francesca, Wei, Ge, Moran, Susan, Roth, Patrick

Volltext

A randomized controlled phase III study of VB-111 combined with bevacizumab vs bevacizumab monotherapy in patients with recurrent glioblastoma (GLOBE) von Cloughesy, Timothy F, Brenner, Andrew, de Groot, John F, Butowski, Nicholas A, Zach, Leor, Campian, Jian L, Ellingson, Benjamin M, Freedman, Laurence S, Cohen, Yael C, Lowenton-Spier, Noa, Rachmilewitz Minei, Tamar, Fain Shmueli, Shifra, Wen, Patrick Y

Volltext

Phase-2 trial of palbociclib in adult patients with recurrent RB1-positive glioblastoma von Taylor, Jennie W., Parikh, Mili, Phillips, Joanna J., James, C. David, Molinaro, Annette M., Butowski, Nicholas A., Clarke, Jennifer L., Oberheim-Bush, Nancy Ann, Chang, Susan M., Berger, Mitchel S., Prados, Michael

Volltext

Mouse models of glioblastoma for the evaluation of novel therapeutic strategies von Haddad, Alexander F, Young, Jacob S, Amara, Dominic, Berger, Mitchel S, Raleigh, David R, Aghi, Manish K, Butowski, Nicholas A

Volltext

Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways von Venneti, Sriram, Kawakibi, Abed Rahman, Ji, Sunjong, Waszak, Sebastian M, Sweha, Stefan R, Mota, Mateus, Pun, Matthew, Deogharkar, Akash, Chung, Chan, Tarapore, Rohinton S, Ramage, Samuel, Chi, Andrew, Wen, Patrick Y, Arrillaga-Romany, Isabel, Batchelor, Tracy T, Butowski, Nicholas A, Sumrall, Ashley, Shonka, Nicole, Harrison, Rebecca A, de Groot, John, Mehta, Minesh, Hall, Matthew D, Daghistani, Doured, Cloughesy, Timothy F, Ellingson, Benjamin M, Beccaria, Kevin, Varlet, Pascale, Kim, Michelle M, Umemura, Yoshie, Garton, Hugh, Franson, Andrea, Schwartz, Jonathan, Jain, Rajan, Kachman, Maureen, Baum, Heidi, Burant, Charles F, Mottl, Sophie L, Cartaxo, Rodrigo T, John, Vishal, Messinger, Dana, Qin, Tingting, Peterson, Erik, Sajjakulnukit, Peter, Ravi, Karthik, Waugh, Alyssa, Walling, Dustin, Ding, Yujie, Xia, Ziyun, Schwendeman, Anna, Hawes, Debra, Yang, Fusheng, Judkins, Alexander R, Wahl, Daniel, Lyssiotis, Costas A, de la Nava, Daniel, Alonso, Marta M, Eze, Augustine, Spitzer, Jasper, Schmidt, Susanne V, Duchatel, Ryan J, Dun, Matthew D, Cain, Jason E, Jiang, Li, Stopka, Sylwia A, Baquer, Gerard, Regan, Michael S, Filbin, Mariella G, Agar, Nathalie Y R, Zhao, Lili, Kumar-Sinha, Chandan, Mody, Rajen, Chinnaiyan, Arul, Kurokawa, Ryo, Pratt, Drew, Yadav, Viveka N, Grill, Jacques, Kline, Cassie, Mueller, Sabine, Resnick, Adam, Nazarian, Javad, Allen, Joshua E, Odia, Yazmin, Gardner, Sharon L, Koschmann, Carl

Volltext

Expression and prognostic impact of immune modulatory molecule PD-L1 in meningioma von Han, Seunggu J., Reis, Gerald, Kohanbash, Gary, Shrivastav, Shruti, Magill, Stephen T., Molinaro, Annette M., McDermott, Michael W., Theodosopoulos, Philip V., Aghi, Manish K., Berger, Mitchel S., Butowski, Nicholas A., Barani, Igor, Phillips, Joanna J., Perry, Arie, Okada, Hideho

Volltext

Editorial. Chronic convection-enhanced delivery: the next frontier in regional drug infusion for glioblastoma von Butowski, Nicholas A., Bringas, John R., Bankiewicz, Krystof S., Aghi, Manish K.

Volltext

Phase I study of RO4929097 with bevacizumab in patients with recurrent malignant glioma von Pan, Edward, Supko, Jeffrey G., Kaley, Thomas J., Butowski, Nicholas A., Cloughesy, Timothy, Jung, Jinkyu, Desideri, Serena, Grossman, Stuart, Ye, Xiaobu, Park, Deric M.

Volltext

Early tumor growth between initial resection and radiotherapy of glioblastoma: incidence and impact on clinical outcomes von Villanueva-Meyer, Javier E., Han, Seunggu J., Cha, Soonmee, Butowski, Nicholas A.

Volltext

Prospective Feasibility Trial for Genomics-Informed Treatment in Recurrent and Progressive Glioblastoma von Byron, Sara A, Tran, Nhan L, Halperin, Rebecca F, Phillips, Joanna J, Kuhn, John G, de Groot, John F, Colman, Howard, Ligon, Keith L, Wen, Patrick Y, Cloughesy, Timothy F, Mellinghoff, Ingo K, Butowski, Nicholas A, Taylor, Jennie W, Clarke, Jennifer L, Chang, Susan M, Berger, Mitchel S, Molinaro, Annette M, Maggiora, Gerald M, Peng, Sen, Nasser, Sara, Liang, Winnie S, Trent, Jeffrey M, Berens, Michael E, Carpten, John D, Craig, David W, Prados, Michael D

Volltext